These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32011103)

  • 1. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
    Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
    Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.
    Jahr G; Broi MD; Holte H; Beiske K; Meling TR
    Brain Behav; 2018 Mar; 8(3):e00928. PubMed ID: 29541540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
    Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
    Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups.
    Gao Y; Wei L; Kim SJ; Wang L; He Y; Zheng Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Theresa PK; Deutsch A; Zhan H; Lai J; Wang Y; You H
    Front Oncol; 2021; 11():696147. PubMed ID: 34422649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.
    Zeremski V; Adolph L; Beer S; Berisha M; Jacobs B; Kahl C; Koenecke C; Kropf S; Panse J; Petersen J; Schmidt-Hieber M; Schneider J; Vucinic V; Walter J; Weigert O; Witte HM; Mougiakakos D
    Eur J Haematol; 2024 Apr; 112(4):641-649. PubMed ID: 38164819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
    Jang JE; Kim YR; Kim SJ; Cho H; Chung H; Lee JY; Park H; Kim Y; Cheong JW; Min YH; Kim JS
    Eur J Cancer; 2016 Apr; 57():127-35. PubMed ID: 26918738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
    van der Meulen M; Dirven L; Bakunina K; van den Bent MJ; Issa S; Doorduijn JK; Bromberg JEC
    J Neurooncol; 2021 Apr; 152(2):357-362. PubMed ID: 33611761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL.
    Da Broi M; Jahr G; Beiske K; Holte H; Meling TR
    Blood Cells Mol Dis; 2018 Nov; 73():25-32. PubMed ID: 30217760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study.
    Wei L; Gao Y; Prochazka KT; Liu R; Wang L; Liu B; He Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Deutsch AJ; Zhan H; Lai J; Kim SJ; You H
    J Neurooncol; 2023 Jun; 163(2):301-311. PubMed ID: 37231231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.
    Velasco R; Mercadal S; Vidal N; Alañá M; Barceló MI; Ibáñez-Juliá MJ; Bobillo S; Caldú Agud R; García Molina E; Martínez P; Cacabelos P; Muntañola A; García-Catalán G; Sancho JM; Camro I; Lado T; Erro ME; Gómez-Vicente L; Salar A; Caballero AC; Solé-Rodríguez M; Gállego Pérez-Larraya J; Huertas N; Estela J; Barón M; Barbero-Bordallo N; Encuentra M; Dlouhy I; Bruna J; Graus F;
    J Neurooncol; 2020 Jul; 148(3):545-554. PubMed ID: 32524392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
    Omuro A; Correa DD; DeAngelis LM; Moskowitz CH; Matasar MJ; Kaley TJ; Gavrilovic IT; Nolan C; Pentsova E; Grommes CC; Panageas KS; Baser RE; Faivre G; Abrey LE; Sauter CS
    Blood; 2015 Feb; 125(9):1403-10. PubMed ID: 25568347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.
    Du KX; Shen HR; Pan BH; Luthuli S; Wang L; Liang JH; Li Y; Yin H; Li JY; Wu JZ; Xu W
    Clin Transl Oncol; 2024 Mar; 26(3):720-731. PubMed ID: 37558851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.
    Abrey LE; Ben-Porat L; Panageas KS; Yahalom J; Berkey B; Curran W; Schultz C; Leibel S; Nelson D; Mehta M; DeAngelis LM
    J Clin Oncol; 2006 Dec; 24(36):5711-5. PubMed ID: 17116938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
    Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
    BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).
    Liu Y; Yao Q; Zhang F
    Int J Oncol; 2021 Mar; 58(3):371-387. PubMed ID: 33650642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cleveland Clinic experience with primary central nervous system lymphoma.
    Xie H; Ahluwalia MS; Peereboom DM
    Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
    Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
    Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of treatment response when managing patients with primary central nervous system lymphoma.
    Chan H; Moraes FY; Berlin A; Crump M; Mason W; Laperriere N; Kuruvilla J; Prica A
    Leuk Lymphoma; 2019 Feb; 60(2):349-357. PubMed ID: 29966463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system lymphoma in immunocompetent individuals: a single center experience.
    Aki H; Uzunaslan D; Saygin C; Batur S; Tuzuner N; Kafadar A; Ongoren S; Oz B
    Int J Clin Exp Pathol; 2013; 6(6):1068-75. PubMed ID: 23696924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.